Compare SUNS & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUNS | APYX |
|---|---|---|
| Founded | 2023 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.1M | 143.2M |
| IPO Year | N/A | 1987 |
| Metric | SUNS | APYX |
|---|---|---|
| Price | $9.23 | $3.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $13.00 | $7.00 |
| AVG Volume (30 Days) | ★ 138.6K | 100.3K |
| Earning Date | 03-05-2026 | 11-06-2025 |
| Dividend Yield | ★ 12.97% | N/A |
| EPS Growth | ★ 1112.46 | N/A |
| EPS | ★ 1.09 | N/A |
| Revenue | $19,384,703.00 | ★ $47,902,000.00 |
| Revenue This Year | $175.51 | $9.36 |
| Revenue Next Year | $63.46 | $6.70 |
| P/E Ratio | $8.48 | ★ N/A |
| Revenue Growth | ★ 2540.16 | N/A |
| 52 Week Low | $7.80 | $0.76 |
| 52 Week High | $14.29 | $4.44 |
| Indicator | SUNS | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 60.21 |
| Support Level | $9.05 | $3.71 |
| Resistance Level | $9.39 | $3.64 |
| Average True Range (ATR) | 0.26 | 0.22 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 27.92 | 87.32 |
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.